Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

RMD - ResMed Inc. So'nggi Yangiliklar | Finranks

Home

RMD

R

ResMed Inc. (RMD)

NYQ – Real vaqt narxi. Valyuta: USD

220.47

-2.03 (-0.91%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

219.40

-1.07 (-0.49%)

Bozordan keyin: Mar 27, 2026, 6:12 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)

After Plunging 12.0% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)

ResMed (RMD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

ResMed (RMD) Upgraded to Buy: Here's What You Should Know

ResMed (RMD) Upgraded to Buy: Here's What You Should Know

ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Resmed Stock the Right Pick for Your Portfolio Now?

Is Resmed Stock the Right Pick for Your Portfolio Now?

RMD expands mask and device sales while maintaining strong liquidity, but macro and competitive pressures loom.

After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)

After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)

The heavy selling pressure might have exhausted for ResMed (RMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

3 Reasons Not to Sleep on ResMed Stock

3 Reasons Not to Sleep on ResMed Stock

ResMed has been growing, and investing in further growth as well -- especially via digital technologies. Its stock is appealingly priced at recent levels.

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise. Over half of respondents get quality sleep on only four nights a week or less.

ResMed At $250: Missed Opportunity Or A Trap In The Making?

ResMed At $250: Missed Opportunity Or A Trap In The Making?

ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a company that is demonstrating reasonable growth, maintaining solid cash flow and margin, has a low-debt capital structure, and is fairly valued.

Videolar

No Data

There is no data to display

Press-relizlar

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach

Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long, healthy life, ahead of diet and exercise. Over half of respondents get quality sleep on only four nights a week or less.

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana

SAN DIEGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, is opening a new distribution center in Greenwood, Indiana. Scheduled to begin operations in 2027, the center will expand Resmed's U.S. presence and strengthen the company's distribution capacity to better serve patients and providers across North America.

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026

Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, beginning at approximately 10:30 a.m. (Pacific Standard Time) in San Francisco, CA.